{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:56:16Z","timestamp":1788782176697,"version":"build-2803163510"},"reference-count":65,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00102","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T02:10:16Z","timestamp":1523585416000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":95,"title":["Lymphoma and Lymphomagenesis in Primary Sj\u00f6gren\u2019s Syndrome"],"prefix":"10.3389","volume":"5","author":[{"given":"Alessia","family":"Alunno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Comasia","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Carubbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","article-title":"Systemic activity and mortality in primary Sj\u00f6gren syndrome: predicting survival using the EULAR-SS disease activity index (ESSDAI) in 1045 patients","volume":"75","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","article-title":"Primary Sjogren\u2019s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients","volume":"53","author":"Baldini","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/rheumatology\/kev354","article-title":"Rate, risk factors and causes of mortality in patients with Sjogren\u2019s syndrome: a systematic review and meta-analysis of cohort studies","volume":"55","author":"Singh","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1177\/000348940010901217","article-title":"Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type","volume":"109","author":"Carbone","year":"2000","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/rheumatology\/kel266","article-title":"Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren\u2019s syndrome","volume":"46","author":"Pijpe","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"50098","DOI":"10.18632\/oncotarget.15100","article-title":"Predictable biomarkers of developing lymphoma in patients with Sj\u00f6gren syndrome: a nationwide population-based cohort study","volume":"8","author":"Chiu","year":"2017","journal-title":"Oncotarget"},{"key":"B8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","article-title":"Characterization and risk estimate of cancer in patients with primary Sj\u00f6gren syndrome","volume":"10","author":"Brito-Zer\u00f3n","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10067-017-3676-8","article-title":"Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study","volume":"37","author":"Wang","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","article-title":"Regulation and function of NK-kappaB transcription factors in the immune system","volume":"27","author":"Vallabhapurapu","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"754825","DOI":"10.1155\/2015\/754825","article-title":"Contribution of genetic factors to Sj\u00f6gren\u2019s syndrome and Sj\u00f6gren\u2019s syndrome related lymphomagenesis","volume":"2015","author":"Nezos","year":"2015","journal-title":"J Immunol Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/sji.12101","article-title":"Association of genes in the NF-kappaB pathway with antibody positive primary Sjogren\u2019s syndrome","volume":"78","author":"Nordmark","year":"2013","journal-title":"Scand J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/sji.12405","article-title":"Low protein A20 in minor salivary glands is associated with lymphoma in primary Sj\u00f6gren\u2019s syndrome","volume":"83","author":"Johnsen","year":"2016","journal-title":"Scand J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","article-title":"Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren\u2019s syndrome","volume":"122","author":"Nocturne","year":"2013","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/art.39518","article-title":"Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sj\u00f6gren\u2019s syndrome","volume":"68","author":"Nocturne","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1136\/annrheumdis-2015-207731","article-title":"Germline variation of TNFAIP3 in primary Sj\u00f6gren\u2019s syndrome-associated lymphoma","volume":"75","author":"Nocturne","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/rheumatology\/kev420","article-title":"Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"55","author":"Thompson","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1084\/jem.20100857","article-title":"A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling","volume":"207","author":"Hildebrand","year":"2010","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0116189","DOI":"10.1371\/journal.pone.0116189","article-title":"Predicting the outcome of Sjogren\u2019s syndrome-associated non-Hodgkin\u2019s lymphoma patients","volume":"10","author":"Papageorgiou","year":"2015","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1002\/art.39231","article-title":"A BAFF receptor His159Tyr mutation in Sjogren\u2019s syndrome-related lymphoproliferation","volume":"67","author":"Papageorgiou","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.autrev.2015.03.004","article-title":"Clinical picture, outcome and predictive factors of lymphoma in Sj\u00f6gren syndrome","volume":"14","author":"Papageorgiou","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaut.2013.04.005","article-title":"B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren\u2019s syndrome","volume":"51","author":"Nezos","year":"2014","journal-title":"J Autoimmun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3816\/CLM.2006.n.003","article-title":"Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: pathogenic role and therapeutic perspectives","volume":"6","author":"Guidoboni","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"B24","first-page":"61","article-title":"High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sj\u00f6gren\u2019s syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type","volume":"32","author":"Fabris","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13075-015-0766-3","article-title":"How hepatitis C virus modifies the immunological profile of Sj\u00f6gren syndrome: analysis of 783 patients","volume":"17","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.autrev.2004.04.004","article-title":"Hepatitis C virus, Sj\u00f6gren\u2019s syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer","volume":"4","author":"Ramos-Casals","year":"2005","journal-title":"Autoimmun Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/rheumatology\/kev385","article-title":"Is salivary gland ultrasonography a useful tool in Sj\u00f6gren\u2019s syndrome? A systematic review","volume":"55","author":"Jousse-Joulin","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrrheum.2010.118","article-title":"Pathogenetic mechanisms in the initiation and perpetuation of Sj\u00f6gren\u2019s syndrome","volume":"6","author":"Voulgarelis","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","article-title":"Ectopic lymphoid neogenesis in rheumatic autoimmune diseases","volume":"13","author":"Bombardieri","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.semarthrit.2014.05.015","article-title":"Is minor salivary gland biopsy more than a diagnostic tool in primary Sj\u00f6gren\u2019s syndrome? Association between clinical, histopathological, and molecular features: a retrospective study","volume":"44","author":"Carubbi","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"B32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/0961203314554251","article-title":"A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"24","author":"Carubbi","year":"2015","journal-title":"Lupus"},{"key":"B33","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/rheumatology\/36.9.969","article-title":"Quantitative assessment of salivary gland inflammatory infiltration in primary Sj\u00f6gren\u2019s syndrome: its relationship to different demographic, clinical and serological features of the disorder","volume":"36","author":"Gerli","year":"1997","journal-title":"Br J Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1136\/annrheumdis-2013-204634","article-title":"The prognostic value of routinely performed minor salivary gland assessments in primary Sj\u00f6gren\u2019s syndrome","volume":"73","author":"Risselada","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sj\u00f6gren\u2019s syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.4049\/jimmunol.179.7.4929","article-title":"Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sj\u00f6gren\u2019s syndrome","volume":"179","author":"Bombardieri","year":"2007","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1136\/annrheumdis-2017-211290","article-title":"Germinal centres in diagnostic labial gland biopsies of patients with primary Sj\u00f6gren\u2019s syndrome are not predictive for parotid MALT lymphoma development","volume":"76","author":"Haacke","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212164","article-title":"Standardisation of the detection of germinal centres in salivary gland biopsies of patients with primary Sj\u00f6gren\u2019s syndrome is needed to assess their clinical relevance","author":"Haacke","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2017.03.012","article-title":"FcRL4\u00fe B-cells in salivary glands of primary Sj\u00f6gren\u2019s syndrome patients","volume":"81","author":"Haacke","year":"2017","journal-title":"J Autoimmun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.semarthrit.2013.03.001","article-title":"Clinical features distinguishing lymphoma development in pSS","volume":"43","author":"Risselada","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"B41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.semarthrit.2012.07.003","article-title":"The role of ectopic germinal centers in the immunopathology of primary Sj\u00f6gren\u2019s syndrome: a systematic review","volume":"42","author":"Risselada","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212108","article-title":"The challenge to interpret conflicting results and the need of a univocal definition for germinal centres in primary Sj\u00f6gren\u2019s syndrome","author":"Alunno","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1136\/annrheumdis-2016-209480","article-title":"Need for consensus guidelines to standardise the assessment of germinal centres and other histopathological parameters in salivary gland tissue of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"75","author":"Delli","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/annrheumdis-2016-210448","article-title":"Standardisation of labial salivary gland histopathology in clinical trials in primary Sj\u00f6gren\u2019s syndrome","volume":"76","author":"Fisher","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fimmu.2013.00290","article-title":"Interferons in Sj\u00f6gren\u2019s syndrome: genes, mechanisms, and effects","volume":"4","author":"Li","year":"2013","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","article-title":"Type I and II interferon signatures in Sjogren\u2019s syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren\u2019s related lymphomagenesis","volume":"63","author":"Nezos","year":"2015","journal-title":"J Autoimmun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/joim.12631","article-title":"The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin\u2019s lymphoma in Sjogren\u2019s syndrome: a prospective, observational, single-center study","volume":"282","author":"Baldini","year":"2017","journal-title":"J Intern Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"30039","DOI":"10.18632\/oncotarget.15613","article-title":"Investigation of three potential autoantibodies in Sjogren\u2019s syndrome and associated MALT lymphoma","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"key":"B49","doi-asserted-by":"publisher","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann Intern Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","article-title":"Biomarkers of lymphoma in Sj\u00f6gren\u2019s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study","volume":"51","author":"Quartuccio","year":"2014","journal-title":"J Autoimmun"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/rheumatology\/kew194","article-title":"Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sj\u00f6gren syndrome: analysis of 515 patients","volume":"55","author":"Retamozo","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3899\/jrheum.161465","article-title":"Cryoglobulinemia in Sj\u00f6gren syndrome: a disease subset that links higher systemic disease activity, autoimmunity, and local B cell proliferation in mucosa-associated lymphoid tissue","volume":"44","author":"Quartuccio","year":"2017","journal-title":"J Rheumatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1002\/art.38129","article-title":"Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sj\u00f6gren\u2019s syndrome","volume":"65","author":"Tob\u00f3n","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/art.39534","article-title":"Monoclonal gammopathy and risk of lymphoma and multiple myeloma in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"68","author":"Tomi","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/art.39315","article-title":"CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary Sjogren\u2019s syndrome","volume":"67","author":"Nocturne","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/bjh.13192","article-title":"Sj\u00f6gren syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"Br J Haematol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e3766","DOI":"10.1097\/MD.0000000000003766","article-title":"Predicting the risk for lymphoma development in Sjogren syndrome","volume":"95","author":"Fragkioudaki","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"20150343","DOI":"10.1259\/dmfr.20150343","article-title":"Dynamic contrast-enhanced MR in the diagnosis of lymphoassociated benign and malignant lesions in the parotid gland","volume":"45","author":"Zhu","year":"2016","journal-title":"Dentomaxillofac Radiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3899\/jrheum.110077","article-title":"Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren\u2019s syndrome: a retrospective clinical study","volume":"38","author":"Pollard","year":"2011","journal-title":"J Rheumatol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","article-title":"Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial","volume":"381","author":"Rummel","year":"2013","journal-title":"Lancet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/acr.21856","article-title":"Using rituximab plus fludarabine and cyclophosphamide as a treatment for refractory mixed cryoglobulinemia associated with lymphoma","volume":"65","author":"Saadoun","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1200\/JCO.2011.40.6272","article-title":"Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized study","volume":"31","author":"Zucca","year":"2013","journal-title":"J Clin Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/ard.2005.046193","article-title":"Long term remission of Sj\u00f6gren\u2019s syndrome associated aggressive B cell non-Hodgkin\u2019s lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)","volume":"65","author":"Voulgarelis","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.beha.2017.11.001","article-title":"Overview on the management of non-gastric MALT lymphomas","volume":"31","author":"Defrancesco","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0b013e31824125e4","article-title":"Prognosis and outcome of non-Hodgkin lymphoma in primary Sj\u00f6gren syndrome","volume":"91","author":"Voulgarelis","year":"2012","journal-title":"Medicine (Baltimore)"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2018.00102\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T02:10:16Z","timestamp":1523585416000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2018.00102\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,13]]},"references-count":65,"alternative-id":["10.3389\/fmed.2018.00102"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00102","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,13]]},"article-number":"102"}}